Adjuvant treatment of penetrating moxibustion at governor vessel for persistent allergic rhinitis of deficiency-cold syndrome.
10.13703/j.0255-2930.20201229-0002
- Author:
Wei-Jie YAO
1
;
Pu-Zhao LIU
1
;
Ya-Li FAN
2
;
Zhi-Cheng ZHANG
1
;
Xiang-Dong GUO
1
;
Xi-Yan GAO
3
Author Information
1. Department of Otolaryngology, First Affiliated Hospital of Henan University of CM, Zhengzhou 450000, China.
2. Department of Acupuncture and Moxibustion, Third Affiliated Hospital of Henan University of CM.
3. College of Acupuncture-Moxibustion and Tuina, Henan University of CM, Zhengzhou 450008.
- Publication Type:Randomized Controlled Trial
- Keywords:
deficiency-cold syndrome;
penetrating moxibustion at governor vessel;
persistent allergic rhinitis;
randomized controlled trial (RCT);
stroke
- MeSH:
Acupuncture Points;
Humans;
Moxibustion;
Quality of Life;
Rhinitis, Allergic/drug therapy*;
Syndrome;
Treatment Outcome
- From:
Chinese Acupuncture & Moxibustion
2021;41(6):623-627
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the efficacy and action mechanism of penetrating moxibustion at governor vessel for persistent allergic rhinitis of deficiency-cold syndrome.
METHODS:Ninety patients with persistent allergic rhinitis of deficiency-cold syndrome were randomly divided into an observation group (
RESULTS:Compared before treatment, the TCM symptom scores, VAS scores, RQLQ scores, serum levels of IgE and complete blood count of EOS in the two groups were all reduced after treatment (
CONCLUSION:Based on the momethasone furoate nasal spray, the adjuvant treatment of penetrating moxibustion at governor vessel could significantly improve the clinical symptoms in patients with persistent allergic rhinitis of deficiency-cold syndrome, and its mechanism may be related to the regulation of immune disorder.
